CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
The influence of hospital characteristics on patient survival in surgically managed metastatic disease of bone: an analysis of the SEER-Medicare linked database
-
8 01 2022
-
Source: Am J Clin Oncol. 45(8):344-351
Details:
-
Alternative Title:Am J Clin Oncol
-
Personal Author:
-
Description:Objectives:
We investigated whether patients receiving surgical treatment for metastatic disease of bone (MDB) at hospitals with higher volume, medical school affiliation, or Commission on Cancer (CoC) accreditation have superior outcomes.
Methods:
Using the SEER-Medicare database, we identified 9,413 patients surgically treated for extremity MDB between 1992–2014 at the age of 66 years or older. Cox proportional hazards models were used to calculate hazards ratios for 90-day and 1-year mortality and 30-day readmission according to characteristics of the hospital where bone surgery was performed.
Results:
We observed no notable differences in 90-day mortality, 1-year mortality, or 30-day readmission associated with hospital volume. Major medical school affiliation was associated with lower 90-day (HR 0.88, 95% CI 0.80–0.96) and 1-year (HR 0.92, 95% CI 0.87–0.99) mortality after adjustments for demographic and tumor characteristics. Surgical treatment at CoC accredited hospitals was associated with significantly higher risk of death at 90 days and 1 year after surgery. This effect appeared to be driven by lung cancer patients (1-year HR 1.17, 95% CI 1.07–1.27).
Conclusions:
Our findings suggest surgical management of MDB at lower volume hospitals does not compromise survival or readmissions. There may be benefit to referral or consultation with an academic medical center in some tumor types or clinical scenarios.
-
Subjects:
-
Keywords:
-
Source:
-
Pubmed ID:35792549
-
Pubmed Central ID:PMC9329267
-
Document Type:
-
Funding:
-
Volume:45
-
Issue:8
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: